Second Opinion: Laetrile At Sloan-kettering
Actors:Ralph W. Moss PhD
The War On Cancer, launched in the early 1970s, set the stage for a massive influx of new ideas in fighting the disease of cancer. Memorial Sloan-Kettering Cancer Center, America's leading cancer research center at the time, was assigned the task of testing an unconventional therapy called â€śLaetrileâ€ť in an effort to curb the publicâ€™s â€śfalse hopeâ€ť in the alleged â€śquackâ€ť therapy. Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Ketteringâ€™s public relations department in 1974 to help brief the American public on the centerâ€™s contribution to the War On Cancer. One of his first assignments was to write a biography about Dr. Kanematsu Sugiura, one of the Centerâ€™s oldest and leading research scientists as well as the original co-inventor of chemotherapy. read more While meeting with this iconic scientist to pen a biography on his 60-year career at Sloan-Kettering, Moss discovered that Sugiura had been studying this â€śquack remedyâ€ť?in laboratory mice, and with unexpectedly positive results. Shocked and bewildered, Moss reported back to his superiors what he had discovered, only to be met with backlash and denial from Sloan-Ketteringâ€™s leaders on what their own leading scientist had found. Fueled by respect and admiration for Sugiuraâ€”Ralph W. Moss attempted to publicize the truth about Sugiuraâ€™s findings. And after all diplomatic approaches failed, Moss started living a double life, working as a loyal employee at Sloan-Kettering while also recruiting fellow employees to help anonymously leak this information to the American publicâ€”?through a newly formed underground organization they calledâ€”â€śSecond Opinionâ€ť.